Catalyst Event
Celltrion Inc (068270) · Other
From Akros SCHK HK-Korea Biotech Index (ASHKBIO)
4/1/2026, 12:00:00 AM
Decided to cancel 9.11 million treasury shares (approx. 4% of total outstanding shares) worth about KRW 1.7154 trillion for shareholder value enhancement, as resolved at the annual general meeting on March 24, 2026. High impact is estimated due to the significant scale of the cancellation. The cancellation on April 1, 2026 is scheduled.
Korean Translation
2026년 3월 24일 정기주주총회 결의에 따라 주주가치 제고를 위해 약 1조 7154억원 규모의 자기주식 911만주(총 발행주식의 약 4%)를 2026년 4월 1일에 소각하기로 결정함. 대규모 소각에 따른 높은 주가 영향이 예상됨. 소각 예정일은 2026년 4월 1일로 예정됨.
Related Recent Events
Samsung Biologics Co Ltd (207940) · Earnings Release
Q1 2026 earnings release scheduled.
4/29/2026, 12:00:00 AM
HLB Co Ltd (028300) · Other
The 41st Annual General Meeting of Shareholders is scheduled for March 31, 2026. Agenda items include the approval of the 2025 financial statements and the appointment of new directors. scheduled
3/31/2026, 12:00:00 AM
LigaChem Biosciences Inc (141080) · Other
20th Annual General Meeting of Shareholders scheduled. Agenda includes approval of 2025 financial statements, appointment of a new internal director, and approval of director compensation limits. A low price impact is estimated as the agenda consists of routine administrative items scheduled.
3/31/2026, 12:00:00 AM
Alteogen Inc (196170) · Other
Alteogen announced an exclusive license agreement with Biogen for its ALT-B4 technology worth up to $579 million on 2026-03-25. A high price impact (>10%) is estimated due to the substantial contract value and strategic partnership.
3/25/2026, 12:00:00 AM
Celltrion Inc (068270) · Other
Entered into a license-in agreement with GoBioLab for three microbiome-based drug candidates for intestinal diseases. The deal is worth up to KRW 205.2 billion, including an upfront payment of KRW 1 billion.
3/25/2026, 12:00:00 AM
Celltrion Inc (068270) · Earnings Release
Announced a 2026 operating profit target of KRW 1.8 trillion at its annual general meeting, with sequential quarterly growth from KRW 300 billion in Q1 to KRW 600 billion in Q4 expected.
3/24/2026, 12:00:00 AM